These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23987570)

  • 1. Behavior of human cytochromes P450 on lipid membranes.
    Berka K; Paloncýová M; Anzenbacher P; Otyepka M
    J Phys Chem B; 2013 Oct; 117(39):11556-64. PubMed ID: 23987570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations.
    Hendrychová T; Anzenbacherová E; Hudeček J; Skopalík J; Lange R; Hildebrandt P; Otyepka M; Anzenbacher P
    Biochim Biophys Acta; 2011 Jan; 1814(1):58-68. PubMed ID: 20656072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences.
    Skopalík J; Anzenbacher P; Otyepka M
    J Phys Chem B; 2008 Jul; 112(27):8165-73. PubMed ID: 18598011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active site.
    Berka K; Hendrychová T; Anzenbacher P; Otyepka M
    J Phys Chem A; 2011 Oct; 115(41):11248-55. PubMed ID: 21744854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferrous and ferric state of cytochromes P450 in intact Escherichia coli cells: a possible role of cytochrome P450-flavodoxin interactions.
    Culka M; Milichovsky J; Jerabek P; Stiborova M; Martinek V
    Neuro Endocrinol Lett; 2015; 36 Suppl 1():29-37. PubMed ID: 26757119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics and hydration of the active sites of mammalian cytochromes P450 probed by molecular dynamics simulations.
    Hendrychova T; Berka K; Navratilova V; Anzenbacher P; Otyepka M
    Curr Drug Metab; 2012 Feb; 13(2):177-89. PubMed ID: 22208532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and dynamics of the membrane-bound cytochrome P450 2C9.
    Cojocaru V; Balali-Mood K; Sansom MS; Wade RC
    PLoS Comput Biol; 2011 Aug; 7(8):e1002152. PubMed ID: 21852944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding a substrate's product regioselectivity in a family of enzymes: a case study of acetaminophen binding in cytochrome P450s.
    Yang Y; Wong SE; Lightstone FC
    PLoS One; 2014; 9(2):e87058. PubMed ID: 24498291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiresolution molecular dynamics simulations reveal the interplay between conformational variability and functional interactions in membrane-bound cytochrome P450 2B4.
    Han SB; Teuffel J; Mukherjee G; Wade RC
    Protein Sci; 2024 Oct; 33(10):e5165. PubMed ID: 39291728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenases.
    Johnson EF; Stout CD
    Biochem Biophys Res Commun; 2005 Dec; 338(1):331-6. PubMed ID: 16157296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple, ligand-dependent routes from the active site of cytochrome P450 2C9.
    Cojocaru V; Winn PJ; Wade RC
    Curr Drug Metab; 2012 Feb; 13(2):143-54. PubMed ID: 22208529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure conservation in cytochromes P450.
    Mestres J
    Proteins; 2005 Feb; 58(3):596-609. PubMed ID: 15617063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Lipid Charge on Membrane Immersion of Cytochrome P450 3A4.
    Navrátilová V; Paloncýová M; Berka K; Otyepka M
    J Phys Chem B; 2016 Nov; 120(43):11205-11213. PubMed ID: 27723344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity.
    Lewis DF
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):369-74. PubMed ID: 10445400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of drug-drug interaction for silymarin.
    Doehmer J; Tewes B; Klein KU; Gritzko K; Muschick H; Mengs U
    Toxicol In Vitro; 2008 Apr; 22(3):610-7. PubMed ID: 18249085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane Interactions, Ligand-Dependent Dynamics, and Stability of Cytochrome P4503A4 in Lipid Nanodiscs.
    Treuheit NA; Redhair M; Kwon H; McClary WD; Guttman M; Sumida JP; Atkins WM
    Biochemistry; 2016 Feb; 55(7):1058-69. PubMed ID: 26814638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part II.
    Mo SL; Zhou ZW; Yang LP; Wei MQ; Zhou SF
    Curr Drug Metab; 2009 Dec; 10(10):1127-50. PubMed ID: 20167000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase.
    Grimm SW; Dyroff MC
    Drug Metab Dispos; 1997 May; 25(5):598-602. PubMed ID: 9152599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational diversity and ligand tunnels of mammalian cytochrome P450s.
    Yu X; Cojocaru V; Wade RC
    Biotechnol Appl Biochem; 2013; 60(1):134-45. PubMed ID: 23587001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the application of the MARTINI coarse-grained model to immersion of a protein in a phospholipid bilayer.
    Mustafa G; Nandekar PP; Yu X; Wade RC
    J Chem Phys; 2015 Dec; 143(24):243139. PubMed ID: 26723624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.